argenx at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
argenx takes part in 2 sessions at Antibody Engineering 2026 in San Diego. Its program covers building new functions into antibody domains and support for early-career scientists. Its research presents an antibody approach that lowers levels of every IgG subclass.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Immunology company developing antibody-based medicines for autoimmune diseases, with marketed FcRn-blocking therapy. | Talk Sun Dec 13 9:00am–9:10am Session Co-Chair Welcome and Opening Remarks Short research talks by scientists within ten years of their graduate degree, plus career advice and time to meet peers. Talk Wed Dec 16 4:15pm–4:45pm A Novel Antibody Approach to Pan-subclass IgG Reduction An antibody that sweeps up and destroys every subtype of the main antibody class in blood, for diseases caused by self-attacking antibodies. Beyond oncology |
Instantly find 20 buyers from argenx
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect, The Antibody Society or Antibody Engineering & Therapeutics. Submit a correction